by Matt Brice | Jun 7, 2017 | Investment Theory
Value investors tend to shy away from technology companies. There are typically two primary reasons for this. First, technology can sometimes be difficult to understand. For example, Nvidia is a technology company that designs graphic processing units. These units...
by John Huber | May 19, 2017 | Ideas, Investment Journal, Investment Theory
This will be a somewhat meandering post on some notes of mine regarding the concept of selling, as well as some brief comments on AutoNation and Verisign (the latter is a current holding). I’ve talked about stocks in category 1 vs category 2. What do I mean by this?...
by Matt Brice | May 12, 2017 | Investment Theory
Buffett Moat vs. Bezos Moat I was a philosophy major, so I have a lot of theories rolling around in my head. Most of them are completely useless. This idea below, however, is probably my best insight into business since I starting reading about investing over a...
by Matt Brice | Apr 28, 2017 | Investment Theory
I have a Dust Bin watchlist. It’s a hodgepodge of companies I have looked at and passed on for one reason or the other. Mainly, I didn’t like the business model, the people running it or the competitive environment. I maintain it because I want to see where I am...
by Matt Brice | Mar 31, 2017 | Investment Journal, Investment Theory
This is an excerpt from my “2016” letter. It will be done before I write the 2017 letter. The Bible has 783,137 words vs. the Ten Commandments, which come in at a mere 297 words. I would probably be better off trying to live the 297 words instead of trying to...
by Matt Brice | Mar 9, 2017 | Investment Journal, Investment Theory
Accretive Health (recently changed its name to R1, stock symbol ACHI) is a revenue cycle management company that was de-listed from the stock exchange a few years back and is preparing to come back to the NASDAQ and play with the grown-ups again. I had originally...
